Sugi Predict

Sugi Predict / Compounds / SCHEMBL22845381

SCHEMBL22845381

SCHEMBL22845381

CC(C)(C)c1ccc(Cl)c(C2CCC2)c1

nearest known ligand 0.38

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ CYP2C19 P33261 2/20 0.38
▸ CYP1A2 P05177 1/20 0.38
▸ CYP2D6 P10635 1/20 0.38
▸ OPRL1 P41146 4/20 0.37
▸ KIF11 P52732 5/20 0.36
▸ ALDH1A1 P00352 1/20 0.34
▸ HPGD P15428 1/20 0.34
▸ ALOX15 P16050 1/20 0.34
▸ HSD17B10 Q99714 1/20 0.34
▸ TDP1 Q9NUW8 1/20 0.34
▸ ACHE P22303 2/20 0.34
▸ GAA P10253 1/20 0.33
▸ SLC6A2 P23975 1/20 0.33
▸ SLC6A4 P31645 1/20 0.33
▸ SLC6A3 Q01959 1/20 0.33
▸ KCNH2 Q12809 1/20 0.33
▸ CNR2 P34972 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18119997 0.93 OPRL1 (0.38) CYP2C19CYP1A2CYP2D6OPRL1KIF11
SCHEMBL22815460 0.83 HTR2A (0.33) CYP2C19CYP1A2CYP2D6OPRL1KIF11
SCHEMBL26795660 0.79 CYP1A2 (0.38) CYP2C19CYP1A2CYP2D6KIF11ALDH1A1
SCHEMBL22815458 0.78 OPRL1 (0.32) CYP2C19OPRL1ALDH1A1HPGDALOX15
SCHEMBL18119996 0.78 CYP2C19 (0.38) CYP2C19CYP1A2CYP2D6OPRL1KIF11
SCHEMBL19780714 0.76 CHRNB2 (0.33) CYP2C19KIF11ALDH1A1HPGDALOX15
SCHEMBL27278204 0.76 PTGDR2 (0.42) CYP2D6OPRL1SLC6A2SLC6A4SLC6A3
SCHEMBL14297623 0.75 KIF11 (0.42) CYP2C19CYP1A2CYP2D6OPRL1KIF11
SCHEMBL11308536 0.75 ALDH1A1 (0.52) CYP2C19CYP1A2CYP2D6KIF11ALDH1A1
SCHEMBL11771173 0.75 CYP1A2 (0.38) CYP2C19CYP1A2CYP2D6KIF11ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230374008-A1 BICYCLIC COMPOUNDS ALIGOS THERAPEUTICS, INC. 2023-11-23 — — US disclosed
US-20230051483-A1 BICYCLIC COMPOUNDS ALIGOS THERAPEUTICS, INC. 2023-02-16 — — US disclosed
US-20220119385-A1 BICYCLIC COMPOUNDS ALIGOS THERAPEUTICS, INC. 2022-04-21 — — US disclosed
US-11136321-B2 Tricyclic compounds ALIGOS THERAPEUTICS, INC. (US) 2021-10-05 — — US disclosed
US-20200407361-A1 TRICYCLIC COMPOUNDS ALIGOS THERAPEUTICS, INC. 2020-12-31 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220119385-A1 BICYCLIC COMPOUNDS SLC10A1, PKD1, CYP11B2 CYP2C19 20/4885CYP1A2 107/4885CYP2D6 92/4885
US-20230051483-A1 BICYCLIC COMPOUNDS SLC10A1, PKD1, CYP11B2 CYP2C19 20/4885CYP1A2 107/4885CYP2D6 92/4885
US-11136321-B2 Tricyclic compounds SLC10A1, PKD1, CEL CYP2C19 11/4885CYP1A2 86/4885CYP2D6 81/4885
US-20230374008-A1 BICYCLIC COMPOUNDS SLC10A1, PKD1, CYP11B2 CYP2C19 20/4885CYP1A2 107/4885CYP2D6 92/4885
US-20200407361-A1 TRICYCLIC COMPOUNDS SLC10A1, PKD1, CEL CYP2C19 11/4885CYP1A2 86/4885CYP2D6 81/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.